Semaglutide Weight Loss in South Africa: How It Works, Cost and Results

If you have heard of Ozempic or Wegovy, you have already heard of semaglutide — you just may not have known the chemical name. Semaglutide is the active molecule behind both brands, and it is currently one of the most clinically studied and widely prescribed weight loss treatments in the world. In South Africa, demand has been running ahead of supply since 2023. This guide breaks down exactly how semaglutide works, what weight loss results look like in clinical trials and real life, what it costs locally, and the questions you should ask your doctor before starting.

What Is Semaglutide?

Semaglutide is a GLP-1 receptor agonist — a synthetic version of glucagon-like peptide-1, a hormone your gut naturally releases after eating. GLP-1 tells your brain you are full, slows stomach emptying, and stimulates insulin release. Semaglutide mimics all of these effects but lasts far longer than the natural hormone — about a week from a single injection.

It was originally developed by Danish pharmaceutical company Novo Nordisk to treat type 2 diabetes (sold as Ozempic). Researchers noticed patients on semaglutide were losing significant amounts of weight as a side effect. Novo Nordisk then developed a higher-dose formulation specifically for obesity management — Wegovy — which received approval in multiple markets including South Africa.

How Does Semaglutide Cause Weight Loss?

Semaglutide drives weight loss through several overlapping mechanisms:

• Appetite suppression: Acts on the hypothalamus to reduce hunger signals. Many users report simply not thinking about food between meals — a dramatic shift for people who have struggled with constant cravings.
• Slowed gastric emptying: Food moves more slowly from the stomach to the small intestine, prolonging the feeling of fullness after smaller portions.
• Reduced food reward: Studies suggest semaglutide dampens the brain's dopamine-driven response to high-fat, high-sugar foods — making that koeksister or packet of crisps less compelling.
• Improved insulin sensitivity: Better blood sugar regulation reduces the energy crashes that trigger hunger and snacking cycles.

The net result: most people naturally eat less without white-knuckling willpower. For many South Africans who have spent years on restrictive diets that eventually fail, this represents a fundamentally different approach.

What Weight Loss Results Can You Expect?

The STEP clinical trial programme — the largest semaglutide weight loss study to date — provides the clearest benchmarks:

• STEP 1 (2021): Participants on 2.4 mg weekly semaglutide lost an average of 14.9% of body weight over 68 weeks vs 2.4% on placebo. About one-third lost more than 20%.
• STEP 2 (type 2 diabetes patients): Average weight loss of 9.6% — lower than non-diabetic patients but still clinically significant.
• STEP 4 (withdrawal trial): People who stopped semaglutide after 20 weeks regained two-thirds of lost weight within a year — underlining that this is an ongoing treatment, not a short-term fix.

Real-world results are generally in line with trials when the drug is used consistently with dietary changes. Without lifestyle modification, results are more modest.

Semaglutide in South Africa: What Is Available?

South Africa currently has two approved semaglutide products:

Ozempic (0.25 mg, 0.5 mg, 1 mg weekly)

Ozempic is registered for type 2 diabetes management in South Africa. Many doctors prescribe it off-label for weight loss — a legal and common practice. The dose is escalated gradually over months to minimise side effects. It is available at most major pharmacy chains including Clicks, Dis-Chem, and Medirite, subject to supply.

Wegovy (0.25 mg escalating to 2.4 mg weekly)

Wegovy is the higher-dose formulation approved specifically for chronic weight management. It requires a BMI of 30+ (or 27+ with a weight-related comorbidity) for prescription. Supply in South Africa has been intermittent — stock tends to sell through quickly at launch windows.

Generic Semaglutide

Compounded and generic semaglutide options have begun appearing in SA via compounding pharmacies. These are significantly cheaper but fall outside the standard regulatory approval pathway — quality, concentration accuracy, and sterility vary. Always use a reputable pharmacy and get a prescription from a registered doctor. For a deep dive into legality, pricing, salt form risks, and how to verify a pharmacy, see our compounded semaglutide South Africa guide.

Semaglutide Cost in South Africa (2026)

Cost is the primary barrier for most South Africans. Medical aid coverage is limited and inconsistent.

• Ozempic 1 mg pen (4 weekly doses): Approximately R2,200 — R2,800 per month
• Wegovy 2.4 mg (maintenance dose): Approximately R3,500 — R4,500 per month where available
• Compounded semaglutide: R800 — R1,500 per month (varies by pharmacy and concentration)
• Doctor consultation: R500 — R1,200 per visit depending on specialist vs GP

Discovery Health, Momentum, and Bonitas have each issued guidance on semaglutide coverage — check your plan's chronic medication benefits and whether obesity is classified as a Prescribed Minimum Benefit condition under your scheme.

For a broader comparison of injectable weight loss options and their SA pricing, see our weight loss injections South Africa guide.

Semaglutide vs Other GLP-1 Options

Semaglutide is not the only GLP-1 treatment available in South Africa. Here is how it compares to the main alternatives:

• Tirzepatide (Mounjaro): A dual GIP/GLP-1 agonist showing average weight loss of 20%+ in trials — meaningfully better than semaglutide. Becoming available in SA but at higher cost.
• Liraglutide (Saxenda): The first GLP-1 approved for obesity in SA. Daily injection vs weekly for semaglutide. Average weight loss around 8% — less effective than semaglutide, but established and widely available.
• Saxenda vs Ozempic: See our full head-to-head comparison for cost, convenience, and results.

Common Side Effects

The most frequently reported side effects are gastrointestinal and typically peak during dose escalation:

• Nausea (most common — affects up to 44% of users at some point)
• Vomiting
• Diarrhoea or constipation
• Stomach discomfort or bloating
• Fatigue during the first few weeks

These effects usually improve as your body adjusts. Eating smaller, lower-fat meals and avoiding rich foods during the first weeks helps significantly. Rooibos tea and ginger have anecdotally helped South African users manage nausea — mild, but worth trying alongside medical guidance.

Rare but serious concerns include pancreatitis, gallbladder issues, and — based on animal studies (not confirmed in humans) — a potential signal for thyroid C-cell tumours. Semaglutide is contraindicated in people with a personal or family history of medullary thyroid carcinoma or MEN2 syndrome.

Facial volume loss ("Ozempic face") can occur with significant rapid weight loss. See our Ozempic face South Africa guide for prevention tips.

Who Is a Good Candidate?

South African clinical guidelines generally support semaglutide for weight management when:

• BMI is 30 kg/m² or above, or
• BMI is 27 kg/m² or above with at least one weight-related health condition (type 2 diabetes, hypertension, sleep apnoea, high cholesterol)
• Lifestyle changes alone have not achieved adequate weight loss
• No contraindications (thyroid cancer history, pregnancy, severe gastrointestinal disease)

A GP or endocrinologist can assess your full metabolic profile and recommend the most appropriate starting dose and escalation schedule. Do not start semaglutide without a proper consultation — this is a prescription medication and dosing matters.

Tips for Getting the Best Results in South Africa

• Pair with protein: Biltong, eggs, legumes, and fish help preserve muscle mass during weight loss — critical on a drug that reduces overall appetite.
• Do not skip resistance training: Weight loss on semaglutide includes muscle tissue if you are not exercising. Even two sessions per week makes a measurable difference to body composition.
• Use the dose escalation schedule: Rushing to the full dose causes unnecessary nausea. The 16-week escalation period exists for a reason.
• Monitor for supply gaps: SA supply is not always guaranteed. Keep your pharmacy informed of your schedule and ask about waitlists.
• Plan for long-term use: STEP 4 data shows weight returns without the drug. Budget and plan accordingly — or discuss with your doctor whether you qualify for indefinite maintenance dosing.

Bottom Line

Semaglutide is the most effective pharmacological weight loss option most South Africans have access to right now. The clinical evidence is strong, the mechanism is well understood, and real-world results match the trial data when the drug is used correctly alongside lifestyle changes. The main barriers are cost and intermittent supply — both of which require planning.

If you are considering semaglutide, start with a proper consultation. Use our guides on Ozempic, Wegovy, and generic semaglutide to understand your options before your appointment — you will have better, more targeted questions for your doctor.

Always consult a registered healthcare professional before starting any prescription weight loss medication. This article is for informational purposes only and does not constitute medical advice.